{"created":"2021-03-01T06:25:48.264696+00:00","id":20815,"links":{},"metadata":{"_buckets":{"deposit":"53d2e4c0-e28e-40a1-af42-91697b2613fb"},"_deposit":{"id":"20815","owners":[],"pid":{"revision_id":0,"type":"depid","value":"20815"},"status":"published"},"_oai":{"id":"oai:niigata-u.repo.nii.ac.jp:00020815"},"item_7_alternative_title_1":{"attribute_name":"\u305d\u306e\u4ed6\u306e\u30bf\u30a4\u30c8\u30eb","attribute_value_mlt":[{"subitem_alternative_title":"Evaluation of Molecular Markers of Blood Coagulation and Fibrinolysis in Patients with Renal Diseases"}]},"item_7_biblio_info_6":{"attribute_name":"\u66f8\u8a8c\u60c5\u5831","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"1992-08","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"8","bibliographicPageEnd":"743","bibliographicPageStart":"739","bibliographicVolumeNumber":"106","bibliographic_titles":[{"bibliographic_title":"\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c"},{"bibliographic_title":"\u65b0\u6f5f\u533b\u5b66\u4f1a\u96d1\u8a8c","bibliographic_titleLang":"en"}]}]},"item_7_description_4":{"attribute_name":"\u6284\u9332","attribute_value_mlt":[{"subitem_description":"Thrombosis is one of the main complications in patients with renal diseases, especially nephrotic syndrome. Previously, urinary FDP or fibrinopeptide A has been used as a thrombotic markers in these patients. I measured plasma levels of various coagulation and fibrinolytic markers in 32 patients with renal diseases. Plasma concentration of plasmin-\u03b1_2-plasmin inhibitor complex (PIC), thrombin-antithrombin III complex (TAT) and D-dimer were significantly elevated in patients with renal diseases as compared to healty subjects\uff1b0.85\u00b10.70 vs 0.24\u00b10.13 \u03bcg/ml, 2.94\u00b11.11 vs 1.86\u00b10.47 \u03bcg/1,185.58\u00b1269.41 vs 30\u00b114 ng/ml, respectevely. Plasma PIC and TAT levels were relatively high in patients with rapidly progressive glomerular nephntis (RPGN) and lupus glomerular nephritis (lupus GN). These findings indicate that these molecular markers were useful for the assessment of hypercoagulable and/or hyperfibrinolytic renal diseases.","subitem_description_type":"Abstract"}]},"item_7_full_name_3":{"attribute_name":"\u8457\u8005\u5225\u540d","attribute_value_mlt":[{"nameIdentifiers":[{"nameIdentifier":"128097","nameIdentifierScheme":"WEKO"}],"names":[{"name":"Wada, Ken"}]}]},"item_7_publisher_7":{"attribute_name":"\u51fa\u7248\u8005","attribute_value_mlt":[{"subitem_publisher":"\u65b0\u6f5f\u533b\u5b66\u4f1a"}]},"item_7_select_19":{"attribute_name":"\u8457\u8005\u7248\u30d5\u30e9\u30b0","attribute_value_mlt":[{"subitem_select_item":"publisher"}]},"item_7_source_id_11":{"attribute_name":"\u66f8\u8a8c\u30ec\u30b3\u30fc\u30c9ID","attribute_value_mlt":[{"subitem_source_identifier":"AN00182415","subitem_source_identifier_type":"NCID"}]},"item_7_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"00290440","subitem_source_identifier_type":"ISSN"}]},"item_creator":{"attribute_name":"\u8457\u8005","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"\u548c\u7530, \u7814"}],"nameIdentifiers":[{"nameIdentifier":"128096","nameIdentifierScheme":"WEKO"}]}]},"item_files":{"attribute_name":"\u30d5\u30a1\u30a4\u30eb\u60c5\u5831","attribute_type":"file","attribute_value_mlt":[{"accessrole":"open_date","date":[{"dateType":"Available","dateValue":"2019-08-16"}],"displaytype":"detail","filename":"106(08)_739-743.pdf","filesize":[{"value":"765.1 kB"}],"format":"application/pdf","licensetype":"license_note","mimetype":"application/pdf","url":{"label":"106(08)_739-743.pdf","url":"https://niigata-u.repo.nii.ac.jp/record/20815/files/106(08)_739-743.pdf"},"version_id":"2f2b4f3a-c943-45e6-b2e3-99c7f1760f59"}]},"item_keyword":{"attribute_name":"\u30ad\u30fc\u30ef\u30fc\u30c9","attribute_value_mlt":[{"subitem_subject":"renal diseases","subitem_subject_scheme":"Other"},{"subitem_subject":"molecular marker","subitem_subject_scheme":"Other"},{"subitem_subject":"thrombin-antithrombin III complex","subitem_subject_scheme":"Other"},{"subitem_subject":"plasmin-\u03b1_2-plasnin inhibitor complex","subitem_subject_scheme":"Other"},{"subitem_subject":"D-dimer","subitem_subject_scheme":"Other"},{"subitem_subject":"\u814e\u75be\u60a3","subitem_subject_scheme":"Other"},{"subitem_subject":"\u5206\u5b50\u30de\u30fc\u30ab\u30fc","subitem_subject_scheme":"Other"},{"subitem_subject":"\u30c8\u30ed\u30f3\u30d3\u30f3-\u30a2\u30f3\u30c1\u30c8\u30ed\u30f3\u30d3\u30f3III\u8907\u5408\u4f53","subitem_subject_scheme":"Other"},{"subitem_subject":"\u30d7\u30e9\u30b9\u30df\u30f3\u03b1_2\u30d7\u30e9\u30b9\u30df\u30f3\u30a4\u30f3\u30d2\u30d3\u30bf\u30fc\u8907\u5408\u4f53","subitem_subject_scheme":"Other"},{"subitem_subject":"D\u30c0\u30a4\u30de\u30fc","subitem_subject_scheme":"Other"}]},"item_language":{"attribute_name":"\u8a00\u8a9e","attribute_value_mlt":[{"subitem_language":"jpn"}]},"item_resource_type":{"attribute_name":"\u8cc7\u6e90\u30bf\u30a4\u30d7","attribute_value_mlt":[{"resourcetype":"departmental bulletin paper","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"\u5404\u7a2e\u814e\u75be\u60a3\u306b\u304a\u3051\u308b\u8840\u6db2\u51dd\u56fa\u7dda\u6eb6\u5206\u5b50\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e","item_titles":{"attribute_name":"\u30bf\u30a4\u30c8\u30eb","attribute_value_mlt":[{"subitem_title":"\u5404\u7a2e\u814e\u75be\u60a3\u306b\u304a\u3051\u308b\u8840\u6db2\u51dd\u56fa\u7dda\u6eb6\u5206\u5b50\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e"},{"subitem_title":"\u5404\u7a2e\u814e\u75be\u60a3\u306b\u304a\u3051\u308b\u8840\u6db2\u51dd\u56fa\u7dda\u6eb6\u5206\u5b50\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e","subitem_title_language":"en"}]},"item_type_id":"7","owner":"1","path":["453/456","471/537/538/1171"],"pubdate":{"attribute_name":"\u516c\u958b\u65e5","attribute_value":"2016-03-18"},"publish_date":"2016-03-18","publish_status":"0","recid":"20815","relation_version_is_last":true,"title":["\u5404\u7a2e\u814e\u75be\u60a3\u306b\u304a\u3051\u308b\u8840\u6db2\u51dd\u56fa\u7dda\u6eb6\u5206\u5b50\u30de\u30fc\u30ab\u30fc\u306e\u691c\u8a0e"],"weko_creator_id":"1","weko_shared_id":null},"updated":"2021-03-01T13:56:08.034435+00:00"}